WO2008020260A3 - Utilisation de sidérophores dans la prévention des maladies vasculaires essentiellement causées par un dysfonctionnement des cellules de l'endothélium, production de sidérophores et évaluation des produits carnés contenant des sidérophores - Google Patents

Utilisation de sidérophores dans la prévention des maladies vasculaires essentiellement causées par un dysfonctionnement des cellules de l'endothélium, production de sidérophores et évaluation des produits carnés contenant des sidérophores Download PDF

Info

Publication number
WO2008020260A3
WO2008020260A3 PCT/HU2007/000076 HU2007000076W WO2008020260A3 WO 2008020260 A3 WO2008020260 A3 WO 2008020260A3 HU 2007000076 W HU2007000076 W HU 2007000076W WO 2008020260 A3 WO2008020260 A3 WO 2008020260A3
Authority
WO
WIPO (PCT)
Prior art keywords
siderophores
production
vascular diseases
qualifying
products
Prior art date
Application number
PCT/HU2007/000076
Other languages
English (en)
Other versions
WO2008020260A2 (fr
Inventor
Jozsef Balla
Gyoergy Balla
Istvan Pocsi
Laszlo Fesues
Viktoria Jeney
Imre Pocsi
Tamas Emri
Gyoengyi Gyemant
Gyula Roman
Istvan Kovacs
Original Assignee
R Ko N Kft
Jozsef Balla
Gyoergy Balla
Istvan Pocsi
Laszlo Fesues
Viktoria Jeney
Imre Pocsi
Tamas Emri
Gyoengyi Gyemant
Gyula Roman
Istvan Kovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0600653A external-priority patent/HU0600653D0/hu
Priority claimed from HU0700535A external-priority patent/HUP0700535A2/hu
Application filed by R Ko N Kft, Jozsef Balla, Gyoergy Balla, Istvan Pocsi, Laszlo Fesues, Viktoria Jeney, Imre Pocsi, Tamas Emri, Gyoengyi Gyemant, Gyula Roman, Istvan Kovacs filed Critical R Ko N Kft
Publication of WO2008020260A2 publication Critical patent/WO2008020260A2/fr
Publication of WO2008020260A3 publication Critical patent/WO2008020260A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention se rapporte à l'utilisation de sidérophores fongiques dans le traitement des maladies vasculaires essentiellement causées par les cellules de l'endothélium, les composants selon ladite invention convenant particulièrement à une administration par voie orale. L'invention concerne également une voie de production privilégiée de sidérophores fongiques par l'utilisation d'espèces fongiques spécifiquement isolées et sélectionnées, ainsi que des aliments, et de préférence des produits carnés, en particulier la saucisse et le salami, qui contiennent des sidérophores en quantité efficace et contrôlée. L'invention se rapporte de plus à un système d'évaluation permettant de déterminer si différents aliments ont un effet préventif sur le système vasculaire, comme décrit ci-dessus.
PCT/HU2007/000076 2006-08-16 2007-08-16 Utilisation de sidérophores dans la prévention des maladies vasculaires essentiellement causées par un dysfonctionnement des cellules de l'endothélium, production de sidérophores et évaluation des produits carnés contenant des sidérophores WO2008020260A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HUP0600653 2006-08-16
HU0600653A HU0600653D0 (en) 2006-08-16 2006-08-16 Process for producing siderofor and siderofor-laden meat-product and use thereof
HUP0700535 2007-08-14
HU0700535A HUP0700535A2 (en) 2007-08-14 2007-08-14 Siderofor use for treatment vascular system, process for producing siderofor, and meat product that contain siderofor and qualification thereof

Publications (2)

Publication Number Publication Date
WO2008020260A2 WO2008020260A2 (fr) 2008-02-21
WO2008020260A3 true WO2008020260A3 (fr) 2008-10-02

Family

ID=89987695

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HU2007/000076 WO2008020260A2 (fr) 2006-08-16 2007-08-16 Utilisation de sidérophores dans la prévention des maladies vasculaires essentiellement causées par un dysfonctionnement des cellules de l'endothélium, production de sidérophores et évaluation des produits carnés contenant des sidérophores

Country Status (1)

Country Link
WO (1) WO2008020260A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2482130C2 (ru) 2008-03-14 2013-05-20 Астеллас Фарма Инк. Циклическое соединение и его соль
ES2408190T3 (es) 2008-03-14 2013-06-18 Astellas Pharma Inc. Microorganismo productor de un compuesto cíclico
GB201115417D0 (en) * 2011-09-06 2011-10-19 Ip Science Ltd Products and methods
CN105018352A (zh) * 2015-07-23 2015-11-04 云南大学 一种产曲酸真菌菌株及制备方法
CN114958946B (zh) * 2022-03-09 2024-03-26 山西勰成生物科技有限公司 一种发酵型红枣螯合肽铁的制备方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3297526A (en) * 1962-04-05 1967-01-10 Ciba Geigy Corp Process for producing coprogen and desferricoprogen
US3326885A (en) * 1962-02-16 1967-06-20 Ciba Geigy Corp Cyclic hexapeptides related to ferrichrome and ferrichrome a
US3342795A (en) * 1962-03-02 1967-09-19 Ciba Geigy Corp Ferrichrysin, desferrichrysin, and derivatives thereof
US5573800A (en) * 1989-02-21 1996-11-12 Viskase Corporation Antimicrobial composition for surface treatment of foodstuffs
US20040170728A1 (en) * 2003-02-28 2004-09-02 Kraft Foods Holdings, Inc. Use of siderophores and organic acids to retard lipid oxidation
WO2005067970A1 (fr) * 2004-01-14 2005-07-28 Gekkeikan Sake Co., Ltd. Complement de fer et son utilisation

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3326885A (en) * 1962-02-16 1967-06-20 Ciba Geigy Corp Cyclic hexapeptides related to ferrichrome and ferrichrome a
US3342795A (en) * 1962-03-02 1967-09-19 Ciba Geigy Corp Ferrichrysin, desferrichrysin, and derivatives thereof
US3297526A (en) * 1962-04-05 1967-01-10 Ciba Geigy Corp Process for producing coprogen and desferricoprogen
US5573800A (en) * 1989-02-21 1996-11-12 Viskase Corporation Antimicrobial composition for surface treatment of foodstuffs
US20040170728A1 (en) * 2003-02-28 2004-09-02 Kraft Foods Holdings, Inc. Use of siderophores and organic acids to retard lipid oxidation
WO2005067970A1 (fr) * 2004-01-14 2005-07-28 Gekkeikan Sake Co., Ltd. Complement de fer et son utilisation
EP1704871A1 (fr) * 2004-01-14 2006-09-27 Gekkeikan Sake Co., Ltd. Complement de fer et son utilisation

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BURT W R: "IDENTIFICATION OF COPROGEN B AND ITS BREAKDOWN PRODUCTS FROM HISTOPLASMA-CAPSULATUM", INFECTION AND IMMUNITY, vol. 35, no. 3, 1982, pages 990 - 996, XP002465556, ISSN: 0019-9567 *
DUFFY STEPHEN J ET AL: "Iron chelation improves endothelial function in patients with coronary artery disease", CIRCULATION, vol. 103, no. 23, 12 June 2001 (2001-06-12), pages 2799 - 2804, XP002465555, ISSN: 0009-7322 *
FREDERICK C B ET AL: "PRODUCTION AND ISOLATION OF SIDEROPHORES FROM THE SOIL FUNGUS EPICOCCUM-PURPURASCENS", BIOCHEMISTRY, vol. 20, no. 9, 1981, pages 2432 - 2436, XP002465557, ISSN: 0006-2960 *
FREDERICK ET AL: "The structure of the fungal siderophore, isotriornicin", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 105, no. 1, 1982, pages 133 - 138, XP009094278, ISSN: 0006-291X *
JALAL M A ET AL: "N alpha-dimethylcoprogens. Three novel trihydroxamate siderophores from pathogenic fungi.", BIOLOGY OF METALS 1988, vol. 1, no. 1, 1988, pages 4 - 8, XP002465558, ISSN: 0933-5854 *
KONETSCHNY-RAPP S ET AL: "HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY OF SIDEROPHORES FROM FUNGI", BIOLOGY OF METALS, SPRINGER VERLAG, BERLIN, DE, vol. 1, no. 1, 1 January 1988 (1988-01-01), pages 9 - 17, XP000984424, ISSN: 0933-5854 *
LAICH ET AL: "Isolation of Penicillium nalgiovense strains impaired in penicillin production by disruption of the pcbAB gene and application as starters on cured meat products", MYCOLOGICAL RESEARCH, ELSEVIER, GB, vol. 107, no. 6, 1 June 2003 (2003-06-01), pages 717 - 726, XP022443248, ISSN: 0953-7562 *
MINQIN R ET AL: "The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit", FREE RADICAL BIOLOGY AND MEDICINE, ELSEVIER SCIENCE, XX, vol. 38, no. 9, 1 May 2005 (2005-05-01), pages 1206 - 1211, XP004829702, ISSN: 0891-5849 *
ONG S A ET AL: "SIDEROPHORES IN MICROBIALLY PROCESSED CHEESE", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 27, no. 5, 1979, pages 990 - 995, XP002489693, ISSN: 0021-8561 *
PITT C G ET AL: "THE SELECTION AND EVALUATION OF NEW CHELATING AGENTS FOR THE TREATMENT OF IRON OVERLOAD", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, AMERICAN SOCIETY FOR PHARMACOLOGY AND, US, vol. 208, no. 1, 1979, pages 12 - 18, XP002915334, ISSN: 0022-3565 *
RENSHAW JOANNA C ET AL: "Fungal siderophores: Structures, functions and applications", MYCOLOGICAL RESEARCH, ELSEVIER,, GB, vol. 106, no. 10, October 2002 (2002-10-01), pages 1123 - 1142, XP009094238, ISSN: 0953-7562 *

Also Published As

Publication number Publication date
WO2008020260A2 (fr) 2008-02-21

Similar Documents

Publication Publication Date Title
HK1209975A1 (en) Compositions for improving flavor and safety of marinated meat products
EP2233005A3 (fr) Traitement après récolte
WO2008097842A3 (fr) Systèmes d'ingrédients comprenant du tréhalose, produits alimentaires comprenant du tréhalose, et procédés de fabrication de ceux-ci
WO2007088062A3 (fr) Produit alimentaire contenant une protease specifique de la proline, preparation et utilisation dudit produit alimentaire destine a degrader les peptides de gluten toxiques ou allergeniques
PL1688042T3 (pl) Sposób i urządzenie do magazynowania, przetwarzania i wydawania artykułów spożywczych
MY173496A (en) Age production inhibitor
WO2008036932A3 (fr) Compositions et procédés utilisant l'espèce boswellia
WO2008043076A3 (fr) Utilisation d'un ph faible pour modifier la texture de produits à base de protéines végétales structurées
PL1858354T3 (pl) Sposób obróbki żywności, zwłaszcza przedłużania trwałości świeżych wędlin i wyrobów mięsnych
MX2009002681A (es) Rellenos.
WO2005115473A3 (fr) Aliment nutritionnel, composition, traitement et procede d'utilisation
WO2009090237A3 (fr) Dérivés fongicides d'hydroximoyl-tétrazoles
MX355153B (es) Combinaciones de compuestos activos que comprenden derivados de carboxamida y un agente de control biologico.
AU2007263724A8 (en) Preserving products for harvest fruits and vegetables
WO2008020260A3 (fr) Utilisation de sidérophores dans la prévention des maladies vasculaires essentiellement causées par un dysfonctionnement des cellules de l'endothélium, production de sidérophores et évaluation des produits carnés contenant des sidérophores
WO2008007245A3 (fr) Agents de conservation naturels pour la conservation de produits périssables
WO2006128041A3 (fr) Compositions et procedes destines a traiter ou a prevenir un neoplasme chimiomoresistant
UA100971C2 (ru) Пищевая композиция
WO2008128766A3 (fr) Composition de boisson
WO2011080254A3 (fr) Dérivés hydroximoyl-hétérocycles fongicides
WO2007035933A3 (fr) Composition permettant de reduire la migration des graisses dans des produits alimentaires
WO2005097063A3 (fr) Forme posologique de natamycine, son procede de preparation, procede de conservation d'un produit alimentaire et produit alimentaire conserve
ZA200707416B (en) Food preservative system and method for preserving a food composition
MX2008011945A (es) Preservacion mejorada de alimentos procesados.
WO2008122728A3 (fr) Procédé de traitement nématocide des plantes à base d'eugénol et de lécithine(s) et/ou dérivés

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07804518

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07804518

Country of ref document: EP

Kind code of ref document: A2